AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (4.4 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Publishing Language: Chinese

Research Progress in Pharmaceutical Packaging Glasses

Chaoyuan LI1Xiuying LI1( )Yifeng HE1Ping ZHAO1Jiabei LONG1Zhuohao XIAO1( )Jun AI1Zhen FU2
School of Material Science and Engineering, Jingdezhen Ceramic University, Jingdezhen 333403, Jiangxi, China
Shandong Jingyao Glass Group, Linyi 276624, Shandong, China
Show Author Information

Abstract

For more than 100 years, borosilicate glass has been the preferred material for pharmaceutical packaging all around the world. With continuous development of modern medicine industry, new drugs emerge one after another, so that the safety problem of borosilicate glass in the process of liquid medicine packaging and storage becomes increasingly prominent. In the process of long-term contact with liquid medicines, especially alkaline ones, there are risks of peeling, particulate matter generation, drug failure and so on. Therefore, chemical stability of borosilicate glass, especially alkali resistance, needs to be further improved.The global spread of COVID-19 has further accelerated the development and production of high-quality borosilicate glass and new medical packaging glass in the world. Five aspects were systematically summarized in this article, including (Ⅰ) classification of pharmaceutical packaging glass circulating in the market, (Ⅱ) application fields and representative compositions of various commercial glass, (Ⅲ) key preparation processes of high quality borosilicate glass, (Ⅳ) correlations between composition,structure and property, (Ⅴ) composition and properties of novel aluminum silicate pharmaceutical packaging glasses.

CLC number: TQ174.75 Document code: A Article ID: 1000-2278(2023)06-1103-13

References

[1]

ZHANG X Y, LI C Q, ZHAO F Y, et al. Bulletin of the Chinese Ceramic Society, 2022, 41(11): 3952–3959.

[2]

WANG Z K, LIN X T, LIU T Y, et al. Thermal, chemical properties and structure evolution of medical neutral glasses modified by transition metal oxides [J]. Journal of Non-Crystalline Solids, 2022, 595, 121835.

[3]

LU W S, CHEN J Y, WANG T D. Glass, 2015, 42(8): 37–40.

[4]

CAI D X, KUANG B, MAO L L, et al. Glass. 2023, 50(1): 20–29.

[6]

ROBERT A S, PORTER W W. Historical review of glasses used for parenteral packaging [J]. PDA Journal of Pharmaceutical Science and Technology, 2017, 71(4): 279–296.

[7]

LI Y, ZHANG Y L. Chinese Journal of Pharmaceuticals, 2014, 45(12): 1186–1191.

[8]

WANG F, TIAN Y L, YUAN C M. Guangzhou Chemical Industry, 2021, 49(1): 12–14.

[9]

CHEN J, SITI M M I, YANG Z R. Packaging Engineering, 2021, 42(10): 37–43.

[10]

GUADAGNINO E, GUGLIELMI M, NICOLETTI F. Glass: The best material for pharmaceutical packaging [J]. International Journal of Applied Glass Science, 2022, 13(3): 281–291.

[12]
United States Pharmacopeia Convention. General Chapter <660>Containers—Glass [M]//United States Pharmacopeia Convention. The United States Pharmacopeia 41. Rockville: United States Pharmacopeia Convention, Inc., 2021.
[13]

YANG D B, LIU B J. Glass Enamel & Ophthalmic Optics, 2020, 48(2): 29–32.

[14]

BOLTRES B, TRATZKY S, KASS S, et al. There is still room for improvement: Presentation of a neutral borosilicate glass with improved chemical stability for parenteral packaging [J]. PDA Journal of Pharmaceutical Science and Technology, 2016, 70(4): 346–352.

[15]
ASTM Committee E41. Standard specification for glasses in laboratory apparatus: E438 – 92 [S]. West Conshohocken: American Society for Testing and Materials, 2011.
[16]
Technical Committee ISO/TC 48, Laboratory glassware and related apparatus, Subcommittee SC 5, et al. Guidelines on types of glass of normal bulk-production composition and their test methods: IS0 12775: 1997(E) [S]. Geneve: International Organization for Standardization, 1997.
[17]

TIAN Y L, GUO X L, ZHANG J, et al. Glass Enamel & Ophthalmic Optics, 2012, 40(4): 10–14.

[18]

PILLAI S A, CHOBISA D, URIMI D, et al. Pharmaceutical glass interactions: A review of possibilities [J]. Journal of Pharmaceutical Sciences and Research. 2016, 8(2): 103–111.

[19]

ROSEMAN T J, BROWN J A, SCOTHORN W W. Glass for parenteral products: A surface view using the scanning electron microscope [J]. Journal of Pharmaceutical Sciences, 1976, 65(1): 22–29.

[20]

GHORPADE K B, SHINDE S M. Glass delamination in sterile formulations and drug recalls: A review [J]. International Journal of Pharmaceutical Sciences Development Research, 2022, 8(1): 001–005.

[21]

JUAN C D, KEN C, FLYNN C R, et al. Delamination propensity of glass containers for pharmaceutical use: a round robin activity looking for a predictive test [J]. PDA Journal of Pharmaceutical Science and Technology, 2018, 72(6): 553–565.

[22]

ENNIS R D, PRITCHARD R, NAKAMURA C, et al. Glass vials for small volume parenterals: Influence of drug and manufacturing processes on glass delamination [J]. Pharmaceutical Development and Technology, 2001, 6(3): 393–405.

[23]

GUGLIELMI M, BESSEGATO N, CERDAN-DIAZ J, et al. Laboratory intercomparison for the evaluation of the delamination propensity of glass containers for pharmaceutical use [J]. International Journal of Applied Glass Science, 2021, 12(1): 135–144.

[24]
United States Pharmacopeia Convention. General Chapter <1660>Evaluation of the inner surface durability of glass containers [M]//United States Pharmacopeia Convention. The United States Pharmacopeia 41 – National Formulary: Volume 36. Rockville: United States Pharmacopeia Convention, Inc., 2021.
[25]

IACOCCA R G, TOLTL N, ALLGEIER M, et al. Factors affecting the chemical durability of glass used in the pharmaceutical industry [J]. American Association of Pharmaceutical Scientists, 2010, 11(3): 1340–1349.

[26]

GUADAGNINO E, ZUCCATO D. Delamination propensity of pharmaceutical glass containers by accelerated testing with different extraction media [J]. PDA Journal of Pharmaceutical Science and Technology, 2012, 66(2): 116–125.

[27]

SLOEY C, GLEASON C, PHILLIPS J. Determining the delamination propensity of pharmaceutical glass vials using a direct stress method [J]. PDA journal of pharmaceutical science and technology, 2013, 67(1): 35–42.

[28]

LI Y, ZHANG Y L, Chinese Journal of Pharmaceuticals, 2015, 46(3): 293–298.

[29]

TIAN Y L, DENG Y, GUO X L, et al. Glass & Enamel, 2011, 39(4): 1–4.

[33]

GUO Y. Glass Enamel & Ophthalmic Optics, 2021, 49(12): 30–35.

[34]

MIROSLAVA H, VERNEROVÁ M. Influence of fining agents on glass melting: A review, part 1 [J]. Ceramics-Silikáty, 2017, 61(2): 119–126.

[35]

MIROSLAVA H, VERNEROVÁ M. Influence of fining agents on glass melting: A review, part 2 [J]. Ceramics-Silikáty, 2017, 61(3): 202–208.

[36]

ZHENG Z Y. Glass, 2022, 49(6): 1–4.

[37]

LAI W L. Glass & Enamel, 2009, 37(6): 16–21.

[38]

IACOCCA R G, ALLGEIER M. Corrosive attack of glass by a pharmaceutical compound [J]. Journal of Materials Science, 2007, 42(3): 801–811.

[39]

ZHANG H P. China Ceramics, 2013, 49(6): 53–56.

[40]

MA Y L, SRINIVASAN C, LEE S. Visualization and microanalysis of susceptible regions in tubular pharmaceutical glass vials using scanning electron microscopy [J]. Microscopy and Microanalysis, 2020, 26(S2): 2248–2250.

[41]

BIAVATI A, PONCINI M, FERRARINI M, et al. Complexing agents and ph influence on chemical durability of typeⅠmolded glass containers [J]. PDA Journal of Pharmaceutical Science and Technology, 2017, 71(4): 306–316.

[42]

HAN J, HE F, MEI S X, et al. Journal of Wuhan University of Technology, 2015, 37(3): 13–17.

[43]

YANG R, LIU H S, DING Z J, et al. Chemical durability of borosilicate pharmaceutical glasses: Mixed alkaline earth effect with varying[MgO]/[CaO] ratio [J]. Journal of the American Ceramic Society, 2021, 104(8): 3973–3981.

[44]
ECKHART W, ANDREA K, PETER B. Borosilicate glass of high chemical resistance and low viscosity which contains zirconium oxide and lithium oxide: 5736476 [P]. 1998-04-07.
[45]

DU T, TIAN Y L, LI Y M, et al. Bulletin of the Chinese Ceramic Society, 2017, 36(4): 1288–1292.

[46]

KWINDA T I, KOPPKA S, SANDER S A H. Sander, et al. Effect of Al2O3 on phase separation and microstructure of R2O-B2O3-Al2O3-SiO2 glass system (R=Li, Na) [J]. Journal of Non-Crystalline Solids, 2020, 531: 1199849.

[47]

DU W F, KURAOKA K, AKAI T, et al. Study of Al2O3 effect on structural change and phase separation in Na2O-B2O3-SiO2 glass by NMR [J]. Journal of Materials Science, 2000, 35(19): 4865–4871.

[48]

SCHAUT R A, PEANASKY J S, DEMARTINO S E, et al. A new glass option for parenteral packaging [J]. PDA Journal of Pharmaceutical Science and Technology, 2014, 68(5): 527–534.

[49]

SCHAUT R A, HOFF K C, DEMARTINO S E, et al. Enhancing patient safety through the use of a pharmaceutical glass designed to prevent cracked containers [J]. PDA Journal of Pharmaceutical Science and Technology, 2017, 71(6): 511–528.

Journal of Ceramics
Pages 1103-1115
Cite this article:
LI C, LI X, HE Y, et al. Research Progress in Pharmaceutical Packaging Glasses. Journal of Ceramics, 2023, 44(6): 1103-1115. https://doi.org/10.13957/j.cnki.tcxb.2023.06.005

22

Views

0

Downloads

0

Crossref

1

Scopus

Altmetrics

Received: 08 May 2023
Revised: 23 October 2023
Published: 01 December 2023
© 2023 Journal of Ceramics
Return